应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NVAX 诺瓦瓦克斯医药
盘前交易 12-18 07:32:44 EST
9.00
-0.23
-2.49%
盘前
8.98
-0.02
-0.22%
07:17 EST
最高
9.26
最低
8.91
成交量
283.28万
今开
9.16
昨收
9.23
日振幅
3.74%
总市值
14.42亿
流通市值
12.90亿
总股本
1.60亿
成交额
2,565万
换手率
1.98%
流通股本
1.43亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.05%报9.57美元
市场透视 · 12-16 22:33
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.05%报9.57美元
美股异动 | 出售捷克工厂,诺瓦瓦克斯医药涨超12%
智通财经 · 12-06
美股异动 | 出售捷克工厂,诺瓦瓦克斯医药涨超12%
异动解读 | 出售捷克工厂 诺瓦瓦克斯医药盘中大涨14.78%
异动解读 · 12-06
异动解读 | 出售捷克工厂 诺瓦瓦克斯医药盘中大涨14.78%
出售捷克工厂 诺瓦瓦克斯医药涨超12%
智通财经 · 12-06
出售捷克工厂 诺瓦瓦克斯医药涨超12%
美股异动 | 出售捷克工厂 诺瓦瓦克斯医药(NVAX.US)涨超12%
智通财经网 · 12-06
美股异动 | 出售捷克工厂 诺瓦瓦克斯医药(NVAX.US)涨超12%
诺瓦瓦克斯医药盘中异动 早盘快速上涨5.18%
市场透视 · 12-06
诺瓦瓦克斯医药盘中异动 早盘快速上涨5.18%
诺瓦瓦克斯医药以2亿美元出售于捷克的生产设施给诺和诺德
金吾财讯 · 12-05
诺瓦瓦克斯医药以2亿美元出售于捷克的生产设施给诺和诺德
异动解读 | 诺瓦瓦克斯医药夜盘大涨6.63%,出售捷克工厂获2亿美元现金
异动解读 · 12-05
异动解读 | 诺瓦瓦克斯医药夜盘大涨6.63%,出售捷克工厂获2亿美元现金
嗡嗡声--美国股票走势-纳米核能、捷蓝航空、越野飞机
路透中文 · 12-05
嗡嗡声--美国股票走势-纳米核能、捷蓝航空、越野飞机
嗡嗡声--美国股票走势-礼来、通用汽车、美元树
路透中文 · 12-04
嗡嗡声--美国股票走势-礼来、通用汽车、美元树
嗡嗡声--美国股票走势-Salesforce、Heron Therapeutics、Novavax
路透中文 · 12-04
嗡嗡声--美国股票走势-Salesforce、Heron Therapeutics、Novavax
BUZZ-Novavax 因向诺和诺德出售价值 2 亿美元的捷克生产基地而上涨
路透中文 · 12-04
BUZZ-Novavax 因向诺和诺德出售价值 2 亿美元的捷克生产基地而上涨
异动解读 | 出售捷克工厂为诺瓦瓦克斯医药注入现金流 股价夜盘大涨7.61%
异动解读 · 12-04
异动解读 | 出售捷克工厂为诺瓦瓦克斯医药注入现金流 股价夜盘大涨7.61%
诺瓦瓦克斯医药盘中异动 早盘股价大跌5.04%
市场透视 · 11-26
诺瓦瓦克斯医药盘中异动 早盘股价大跌5.04%
诺瓦瓦克斯医药盘中异动 早盘快速上涨5.02%
市场透视 · 11-25
诺瓦瓦克斯医药盘中异动 早盘快速上涨5.02%
美股抗疫概念股集体上涨 Moderna涨超7%
每日经济新闻 · 11-23
美股抗疫概念股集体上涨 Moderna涨超7%
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.04%报8.45美元
市场透视 · 11-22
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.04%报8.45美元
诺瓦瓦克斯医药2024财年第三财季实现净利润-1.21亿美元,同比增加7.63%
市场透视 · 11-19
诺瓦瓦克斯医药2024财年第三财季实现净利润-1.21亿美元,同比增加7.63%
异动解读 | 诺瓦瓦克斯医药盘中大涨7.04%,或受良好的臨床結果推动
异动解读 · 11-18
异动解读 | 诺瓦瓦克斯医药盘中大涨7.04%,或受良好的臨床結果推动
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.05%报7.69美元
市场透视 · 11-18
诺瓦瓦克斯医药盘中异动 早盘股价大涨5.05%报7.69美元
公司概况
公司名称:
诺瓦瓦克斯医药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Novavax, Inc.是一家新型临床阶段生物制药公司,致力于发现、开发和商业化纳米颗粒重组疫苗和佐剂。公司的疫苗技术平台是根据专有纳米疫苗重组技术开发的,包括病毒样颗粒和蛋白质纳米颗粒候选疫苗。公司的候选疫苗是转基因的三维纳米结构,结合了免疫重要蛋白。公司的疫苗产品针对各种传染病,还有目前在临床开发的针对呼吸道合胞体病毒(RSV)、季节性流感和大流行性流感的产品。此外,CPL生物制剂私人有限公司(CPLB),其合资公司在印度,正积极开发一系列疫苗候选产品,是由诺瓦瓦克斯公司转基因完成的。1987年,诺瓦瓦克斯公司在特拉华州的法律下成立。
发行价格:
--
{"stockData":{"symbol":"NVAX","market":"US","secType":"STK","nameCN":"诺瓦瓦克斯医药","latestPrice":9,"timestamp":1734469200000,"preClose":9.23,"halted":0,"volume":2832751,"hourTrading":{"tag":"盘前","latestPrice":8.98,"preClose":9,"latestTime":"07:17 EST","volume":2433,"amount":21789.432204,"timestamp":1734524266339},"delay":0,"floatShares":143363246,"shares":160184994,"eps":-1.990649,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.23,"latestTime":"12-18 07:32:44 EST","open":9.16,"high":9.255,"low":8.91,"amount":25652478.077427,"amplitude":0.037378,"askPrice":9,"askSize":100,"bidPrice":8.9,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.990649,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734532200000},"adr":0,"adjPreClose":9,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.98,"preClose":9,"latestTime":"07:17 EST","volume":2433,"amount":21789.432204,"timestamp":1734524266339},"postHourTrading":{"tag":"盘后","latestPrice":8.97,"preClose":9,"latestTime":"19:58 EST","volume":80875,"amount":727651.8857,"timestamp":1734483501037},"volumeRatio":0.9290390530215632,"impliedVol":1.4696,"impliedVolPercentile":0.9243},"requestUrl":"/m/hq/s/NVAX/wiki","defaultTab":"wiki","newsList":[{"id":"2491697367","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨5.05%报9.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491697367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491697367?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:33","pubTimestamp":1734359583,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时33分,诺瓦瓦克斯医药股票出现异动,股价大幅上涨5.05%。截至发稿,该股报9.57美元/股,成交量24.8722万股,换手率0.16%,振幅5.38%。机构评级方面,在所有6家参与评级的机构中,50%的券商给予买入建议,33%的券商给予持有建议,17%的券商给予卖出建议。诺瓦瓦克斯医药股票所在的生物技术行业中,整体涨幅为0.30%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223303ab7c949c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223303ab7c949c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX","BK4588","BK4585","BK4139","BK4568","BK4547"],"gpt_icon":0},{"id":"2489343992","title":"美股异动 | 出售捷克工厂,诺瓦瓦克斯医药涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489343992","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489343992?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:23","pubTimestamp":1733498600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周五,诺瓦瓦克斯医药股价走高,截至发稿,该股涨超12%,报9.355美元。消息面上,诺瓦瓦克斯医药将其位于捷克的生产设施以2亿美元出售给诺和诺德。根据周三公布的声明,诺瓦瓦克斯医药将向诺和诺德装让一个15万平方英尺的重组蛋白制造设施及配套建筑,现有的劳动力以及所有相关和必要的基础设施。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e23c446e12ee68702ac1996f7cb3a3ca","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221793.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"出售捷克工厂,诺瓦瓦克斯医药股价大涨","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4568","NVAX","BK4547","BK4588","BK4139","BK4585"],"gpt_icon":0},{"id":"1181476557","title":"异动解读 | 出售捷克工厂 诺瓦瓦克斯医药盘中大涨14.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181476557","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181476557?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:22","pubTimestamp":1733498563,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药(NVAX.US)今日盘中大涨14.78%,引发市场关注。\n\n诺瓦瓦克斯医药当日将其位于捷克的一家生产设施以2亿美元的价格出售给诺和诺德公司。这笔交易将为诺瓦瓦克斯医药带来巨额现金收益,增强公司的财务实力。同时也将使公司每年运营成本降低约8000万美元,提高了运营效率。\n\n诺瓦瓦克斯医药表示,此举符合公司之前宣布的承诺,即专注于自身管线资产和技术平台。投资者对公司战略调整和前景抱有信心,推动股价今日大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e23c446e12ee68702ac1996f7cb3a3ca","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2489232577","title":"出售捷克工厂 诺瓦瓦克斯医药涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489232577","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489232577?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:19","pubTimestamp":1733498392,"startTime":"0","endTime":"0","summary":"周五,诺瓦瓦克斯医药股价走高,截至发稿,该股涨超12%,报9.355美元。消息面上,诺瓦瓦克斯医药将其位于捷克的生产设施以2亿美元出售给诺和诺德。根据周三公布的声明,诺瓦瓦克斯医药将向诺和诺德装让一个15万平方英尺的重组蛋白制造设施及配套建筑,现有的劳动力以及所有相关和必要的基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232541ab62f1c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"e23c446e12ee68702ac1996f7cb3a3ca","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232541ab62f1c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4588","NVAX","BK4585","BK4547","BK4139"],"gpt_icon":0},{"id":"2489232964","title":"美股异动 | 出售捷克工厂 诺瓦瓦克斯医药(NVAX.US)涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489232964","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489232964?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:00","pubTimestamp":1733497200,"startTime":"0","endTime":"0","summary":"周五,诺瓦瓦克斯医药股价走高,截至发稿,该股涨超12%,报9.355美元。消息面上,诺瓦瓦克斯医药将其位于捷克的生产设施以2亿美元出售给诺和诺德。根据周三公布的声明,诺瓦瓦克斯医药将向诺和诺德装让一个15万平方英尺的重组蛋白制造设施及配套建筑,现有的劳动力以及所有相关和必要的基础设施。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e23c446e12ee68702ac1996f7cb3a3ca","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2024-12-06/doc-incypxhh8571644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4547","BK4568","BK4585","BK4588","NVAX","BK4139"],"gpt_icon":0},{"id":"2489578232","title":"诺瓦瓦克斯医药盘中异动 早盘快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489578232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489578232?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:36","pubTimestamp":1733495800,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时36分,诺瓦瓦克斯医药股票出现异动,股价快速拉升5.18%。截至发稿,该股报8.73美元/股,成交量27.8376万股,换手率0.17%,振幅3.01%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体涨幅为0.07%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。该公司认为,其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622364098e5e1d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120622364098e5e1d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4139","BK4585","NVAX","BK4568","BK4588"],"gpt_icon":0},{"id":"2488980391","title":"诺瓦瓦克斯医药以2亿美元出售于捷克的生产设施给诺和诺德","url":"https://stock-news.laohu8.com/highlight/detail?id=2488980391","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488980391?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:05","pubTimestamp":1733360732,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺瓦瓦克斯医药(NVAX)将其位于捷克的生产设施以2亿美元出售给诺和诺德(NVO)。根据周三公布的声明,诺瓦瓦克斯医药将向诺和诺德装让一个15万平方英尺的重组蛋白制造设施及配套建筑,现有的劳动力以及所有相关和必要的基础设施。除了2024年1.9亿美元的现金支付和2025年额外的1000万美元外,诺瓦瓦克斯医药预计出售该设施将使每年的运营成本降低约8000万美元。该协议预计将于2024年12月30日完成,届时该生产设施的全部责任将转交给诺和诺德。","market":"us","thumbnail":"https://static.tigerbbs.com/015e8bdc1b4c937bb6bf446ba9f471f1","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/015e8bdc1b4c937bb6bf446ba9f471f1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"282753","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺瓦瓦克斯医药以2亿美元出售于捷克的生产设施给诺和诺德","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4599","NVAX","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","BK4585","IE00BKVL7J92.USD","BK4547","BK4532","BK4568","BK4007"],"gpt_icon":0},{"id":"1196665440","title":"异动解读 | 诺瓦瓦克斯医药夜盘大涨6.63%,出售捷克工厂获2亿美元现金","url":"https://stock-news.laohu8.com/highlight/detail?id=1196665440","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196665440?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:01","pubTimestamp":1733360472,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药(NVAX)股价在今晚的夜盘交易中大涨6.63%。引发这一股价上涨的主要原因是:\n\n该公司宣布将其位于捷克的一处生产设施以2亿美元的价格出售给诺和诺德公司(NVO)。这笔交易预计将为诺瓦瓦克斯带来2亿美元的现金收益,同时每年还能减少约8000万美元的运营成本。\n\n该笔出售不仅可为公司提供充足的流动资金,还有助于降低成本负担,从而提升整体盈利能力。在目前的经济环境下,此举有望为诺瓦瓦克斯带来正面利好,缓解公司的财务压力,提振投资者信心,推动股价上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 诺瓦瓦克斯医药夜盘大涨6.63%,出售捷克工厂获2亿美元现金","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2489055115","title":"嗡嗡声--美国股票走势-纳米核能、捷蓝航空、越野飞机","url":"https://stock-news.laohu8.com/highlight/detail?id=2489055115","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489055115?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:05","pubTimestamp":1733328315,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30,道琼斯工业平均指数.DJI上涨0.31%,报44,846.04点;标准普尔500指数.SPX上涨0.29%,报6,067.26点;纳斯达克综合指数.IXIC上涨0.84%,报19,644.70点。标准普尔 500 指数.PG.INX百分比涨幅前三名是: ** Salesforce Inc CRM.N,上涨 8.8. ** Vistra Corp VST.N,上涨 5.7 标准普尔 500 指数.PL.INX跌幅前三名: ** Globe Life Inc GL.N,下跌 8.2. 由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N5182:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBLU","LU0792757196.USD","AES","GL","ADM","LLY","LU0251131958.USD","LU2362541513.USD","MKTX","BK4596","CBRL","CCRN","LU1951200564.SGD","NVAX","RLMD","VST","CYCN","LU0056508442.USD","MSM","CRM","LU1323610961.USD","BK4155","HRTX","GM","LU2237443895.HKD","SG9999015978.USD","LU0642271901.SGD","LEV","SRM","BK4561","BK4196","CRGY","RBOT","BK4213","DLTR","CURV","AVIR","LU2290526834.HKD","LU1571399168.USD","IE00BMPRXR70.SGD","SG9999014021.USD","ORIS","PSTG","BK4527","NNE"],"gpt_icon":1},{"id":"2488919496","title":"嗡嗡声--美国股票走势-礼来、通用汽车、美元树","url":"https://stock-news.laohu8.com/highlight/detail?id=2488919496","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488919496?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:24","pubTimestamp":1733322276,"startTime":"0","endTime":"0","summary":".N ** Novavax Inc NVAX.O:BUZZ - 因向诺和诺德出售2亿美元捷克生产基地而上涨 nL3N3N50NS ** Heron Therapeutics Inc HRTX.O:BUZZ - 因法院对 Cinvanti 专利的有利裁决而上涨。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N511Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014898.SGD","LU1868836914.USD","GM","SG9999015945.SGD","RLMD","HRTX","CRGY","LU2237443382.USD","BK4504","LLY","LU1046421795.USD","BK4213","SGXZ81514606.USD","MRVL","LU0130102774.USD","LU0251142724.SGD","LU0070302665.USD","LU1803068979.SGD","CRM","BK4559","BK4579","BK4538","LU2491050071.SGD","IE0009355771.USD","BK4516","LU0456855351.SGD","LU0345770308.USD","SG9999018865.SGD","LU0320765489.SGD","LU0187121727.USD","LU0385154629.USD","LU1064131342.USD","LU2236285917.USD","LU2023250504.SGD","LU0251131958.USD","BK4007","DLTR","LU0122379950.USD","LU0096364046.USD","BK4581","IE00BQXX3F31.USD","LU0477156797.USD","LU2322448957.HKD","AVIR","IE00B1BXHZ80.USD","LU0689472784.USD","LU0820561909.HKD","NVAX","BK4550","LU0648001328.SGD"],"gpt_icon":1},{"id":"2488219162","title":"嗡嗡声--美国股票走势-Salesforce、Heron Therapeutics、Novavax","url":"https://stock-news.laohu8.com/highlight/detail?id=2488219162","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488219162?lang=zh_cn&edition=full","pubTime":"2024-12-04 20:12","pubTimestamp":1733314349,"startTime":"0","endTime":"0","summary":".N ** Novavax Inc NVAX.O:BUZZ - 因向诺和诺德出售 2 亿美元捷克生产基地而上涨 nL3N3N50NS ** Heron Therapeutics Inc HRTX.O:BUZZ - 因法院对 Cinvanti 专利的有利裁决而上涨。nL3N3N50RG ** Crescent Energy Co CRGY.N:BUZZ - 在 Ridgemar 交易之后,Gerdes Energy 上调了对 Crescent Energy 的预测价值。nL3N3N50RL ** Salesforce Inc CRM.N:BUZZ - 营收超出预期后大涨,券商上调PT值 nL3N3N50R9 (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3T3N50U2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRGY","HRTX","CRM","NVAX"],"gpt_icon":1},{"id":"2488636811","title":"BUZZ-Novavax 因向诺和诺德出售价值 2 亿美元的捷克生产基地而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2488636811","media":"路透中文","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488636811?lang=zh_cn&edition=full","pubTime":"2024-12-04 18:25","pubTimestamp":1733307913,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"536af9e7a22a2c3129084bce62b13f93","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N50OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4585","BK4547","NVAX","BK4139","BK4588"],"gpt_icon":0},{"id":"1166808189","title":"异动解读 | 出售捷克工厂为诺瓦瓦克斯医药注入现金流 股价夜盘大涨7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166808189","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166808189?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:07","pubTimestamp":1733299641,"startTime":"0","endTime":"0","summary":"诺瓦瓦克斯医药(NVAX)今日夜盘大涨7.61%,引起市场广泛关注。消息面上,该公司已签署协议,以2亿美元的价格将位于捷克共和国博胡米尔的生产设施出售给大型制药公司诺和诺德。\n\n这笔交易为诺瓦瓦克斯医药注入可观的现金流,或将用于优化资产配置、加强公司核心业务发展。出售捷克厂区也被视为公司重整旗鼓、专注优势领域的积极信号,提振了市场对公司长期前景的信心。\n\n与诺和诺德等行业巨头达成交易协议,也进一步提高了诺瓦瓦克斯医药的行业地位和知名度。因此,此次出售捷克生产设施的决策获得了市场的热烈追捧,成为公司夜盘大涨的主因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"536af9e7a22a2c3129084bce62b13f93","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2486885728","title":"诺瓦瓦克斯医药盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486885728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486885728?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:27","pubTimestamp":1732634872,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时27分,诺瓦瓦克斯医药股票出现异动,股价快速下挫5.04%。截至发稿,该股报8.85美元/股,成交量106.255万股,换手率0.66%,振幅4.24%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.56%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。该公司认为,其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232752971a8aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126232752971a8aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4547","BK4568","BK4139","BK4585","NVAX"],"gpt_icon":0},{"id":"2486036519","title":"诺瓦瓦克斯医药盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486036519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486036519?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:21","pubTimestamp":1732548079,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时21分,诺瓦瓦克斯医药股票出现异动,股价急速上涨5.02%。截至发稿,该股报8.90美元/股,成交量88.3444万股,换手率0.55%,振幅3.69%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体涨幅为2.03%。诺瓦瓦克斯医药公司简介:诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。该公司认为,其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232119abde12c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125232119abde12c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4568","BK4547","NVAX","BK4585"],"gpt_icon":0},{"id":"2485024337","title":"美股抗疫概念股集体上涨 Moderna涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485024337","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485024337?lang=zh_cn&edition=full","pubTime":"2024-11-23 06:46","pubTimestamp":1732315596,"startTime":"0","endTime":"0","summary":"当地时间11月22日,美股抗疫概念股集体上涨,Moderna涨超7%,吉利德科学涨0.48%,诺瓦瓦克斯医药涨逾5%,BioNTech涨超4%,阿斯利康涨逾2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411233248531016.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411233248531016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GILD","IE00BSNM7G36.USD","BK4578","LU0234570918.USD","IE0002270589.USD","LU1066053197.SGD","BK4566","IE00B19Z3B42.SGD","LU1585245621.USD","BK4568","LU1571399168.USD","LU0289739699.SGD","BK4550","BK4139","BK4585","BK4583","LU0109394709.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","IE00B19Z3581.USD","LU1430594728.SGD","LU0058720904.USD","BK4547","IE00BKVL7J92.USD","LU1066051498.USD","LU2087621335.USD","LU2468319806.SGD","BK4532","LU0889565916.HKD","NVAX","BK4588"],"gpt_icon":0},{"id":"2485826208","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨5.04%报8.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485826208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485826208?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:08","pubTimestamp":1732288101,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时08分,诺瓦瓦克斯医药股票出现波动,股价大幅上涨5.04%。截至发稿,该股报8.45美元/股,成交量76.6659万股,换手率0.48%,振幅5.35%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体涨幅为0.39%。其相关个股中,Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为1454.79%、104.04%、79.78%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Invizyne Technologies Inc.,振幅分别为48.21%、42.36%、33.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122230822971a81e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122230822971a81e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVAX","BK4547","BK4585","BK4568","BK4588"],"gpt_icon":0},{"id":"2484670312","title":"诺瓦瓦克斯医药2024财年第三财季实现净利润-1.21亿美元,同比增加7.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484670312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484670312?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:00","pubTimestamp":1731945633,"startTime":"0","endTime":"0","summary":"11月19日,诺瓦瓦克斯医药公布财报,公告显示公司2024财年第三财季净利润为-1.21亿美元,同比增加7.63%;其中营业收入为84.51百万美元,同比减少54.81%,每股基本收益为-0.76美元。机构评级:截至2024年11月19日,当前有6家机构对诺瓦瓦克斯医药目标价做出预测,其中目标均价为16.67美元,其中最低目标价为9.00美元,最高目标价为26.00美元。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000053a243527c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119000053a243527c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVAX"],"gpt_icon":1},{"id":"1109785641","title":"异动解读 | 诺瓦瓦克斯医药盘中大涨7.04%,或受良好的臨床結果推动","url":"https://stock-news.laohu8.com/highlight/detail?id=1109785641","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109785641?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:17","pubTimestamp":1731943023,"startTime":"0","endTime":"0","summary":"近期,诺瓦瓦克斯医药股价在盘中出现大幅上涨,报收7.04%。此次股价大涨,或与公司推出的一种新型疫苗的临床试验结果有关。诺瓦瓦克斯医药是一家专注于新型疫苗开发的生物技术公司。行业分析人士表示,如果诺瓦瓦克斯的新型疫苗通过审批并成功上市,将帮助公司大幅改善财务状况,被市场看好。总的来说,这一利好临床进展消息,以及良好的外界评级推动了股价的大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 诺瓦瓦克斯医药盘中大涨7.04%,或受良好的臨床結果推动","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVAX"],"gpt_icon":0},{"id":"2484671493","title":"诺瓦瓦克斯医药盘中异动 早盘股价大涨5.05%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484671493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484671493?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:05","pubTimestamp":1731942327,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时05分,诺瓦瓦克斯医药股票出现异动,股价大幅拉升5.05%。截至发稿,该股报7.69美元/股,成交量108.64万股,换手率0.68%,振幅4.29%。诺瓦瓦克斯医药股票所在的生物技术行业中,整体跌幅为0.37%。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗,以应对已知和新出现的疾病威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230527a2433ad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118230527a2433ad6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","BK4547","NVAX","BK4568"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.novavax.com","stockEarnings":[{"period":"1week","weight":0.0262},{"period":"1month","weight":0.2295},{"period":"3month","weight":-0.2834},{"period":"6month","weight":-0.3599},{"period":"1year","weight":0.7442},{"period":"ytd","weight":0.875}],"compareEarnings":[{"period":"1week","weight":0.0025},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.0764},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.2804},{"period":"ytd","weight":0.2714}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novavax, Inc.是一家新型临床阶段生物制药公司,致力于发现、开发和商业化纳米颗粒重组疫苗和佐剂。公司的疫苗技术平台是根据专有纳米疫苗重组技术开发的,包括病毒样颗粒和蛋白质纳米颗粒候选疫苗。公司的候选疫苗是转基因的三维纳米结构,结合了免疫重要蛋白。公司的疫苗产品针对各种传染病,还有目前在临床开发的针对呼吸道合胞体病毒(RSV)、季节性流感和大流行性流感的产品。此外,CPL生物制剂私人有限公司(CPLB),其合资公司在印度,正积极开发一系列疫苗候选产品,是由诺瓦瓦克斯公司转基因完成的。1987年,诺瓦瓦克斯公司在特拉华州的法律下成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.655172,"avgChangeRate":0.101878},{"month":2,"riseRate":0.586207,"avgChangeRate":0.042134},{"month":3,"riseRate":0.275862,"avgChangeRate":-0.034367},{"month":4,"riseRate":0.448276,"avgChangeRate":0.007943},{"month":5,"riseRate":0.517241,"avgChangeRate":0.126888},{"month":6,"riseRate":0.517241,"avgChangeRate":0.09837},{"month":7,"riseRate":0.551724,"avgChangeRate":0.018176},{"month":8,"riseRate":0.517241,"avgChangeRate":0.037008},{"month":9,"riseRate":0.482759,"avgChangeRate":-0.043221},{"month":10,"riseRate":0.310345,"avgChangeRate":0.029378},{"month":11,"riseRate":0.344828,"avgChangeRate":0.002076},{"month":12,"riseRate":0.413793,"avgChangeRate":-0.03453}],"exchange":"NASDAQ","name":"诺瓦瓦克斯医药","nameEN":"Novavax"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺瓦瓦克斯医药,NVAX,诺瓦瓦克斯医药股票,诺瓦瓦克斯医药股票老虎,诺瓦瓦克斯医药股票老虎国际,诺瓦瓦克斯医药行情,诺瓦瓦克斯医药股票行情,诺瓦瓦克斯医药股价,诺瓦瓦克斯医药股市,诺瓦瓦克斯医药股票价格,诺瓦瓦克斯医药股票交易,诺瓦瓦克斯医药股票购买,诺瓦瓦克斯医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺瓦瓦克斯医药(NVAX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺瓦瓦克斯医药(NVAX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}